Magnus Isaksson retweeted
We are honored to be one of the very first companies in the United States to have received access to the NovaSeq X+, the newest @illumina sequencer to date that we will be using for all of our viral and #DNA sequencing efforts. #technologyinnovator
Magnus Isaksson retweeted
The Helix team was thrilled to see Dr. Dan Judge, principal investigator of In Our DNA SC, take to the podium at #ACC23 in New Orleans last week. Dr. Anwar Chahal from WellSpan was also in attendance to join the discussion on the role of screening in genetic cardiomyopathies.
Magnus Isaksson retweeted
The latest on reinfections from @my_helix:
- ~10% of total infections are reinfections
- ~2% of total reinfections are occurring within 90 days of the previous infection.
In chart, the denominator is total reinfections.
As always, thanks to @McCroneIV @robcrock
#OnTheBlog: With positive #COVID cases officially coming down across the country, our scientists share their hypotheses on why and what this means for the fall in our latest post.
https://nitter.cf/t.co/c5m0jHkElW
Magnus Isaksson retweeted
4/ There are many caveats and nuances. For full details, please check out our easy-to-read 4-page technical briefing cdn.shopify.com/s/files/1/27…
Thanks: @alexbolze @McCroneIV @Maglaar
Also check out @KatherineJWu 's great write-up on this topic: theatlantic.com/health/archi….
Magnus Isaksson retweeted
Register to hear Helix Staff Scientist, @alexbolze share our groundbreaking research on genetic susceptibilities to #COVID-19 vaccine side effects at the @GeneticsSociety Monthly Journal Club in June: https://nitter.cf/t.co/ow91P5eM8x
Magnus Isaksson retweeted
As always thank you to the team at @my_helix @alexbolze @Maglaar for driving this work. I look forward to a day we can monitor all these viruses as well as, if not better than, we do SARS-CoV-2.
Magnus Isaksson retweeted
Interested in combining clinical data and population genomics? Find @genesareclever at #IS22… we’re hiring @my_helix !!
So excited about @AMIAinformatics #IS22, my first in-person conference since the pandemic started. Chat me up if you're here! I'm hiring!
Magnus Isaksson retweeted
Curious about Delta-Omicron recombinants?
Our study 👏 @shishiluo @my_helix: medrxiv.org/content/10.1101/…
Co-circultation of both variants
20 samples with co-infections
Evidence of a few recombinations in co-infections
& 2 infections with 100% recombinant
Details in 🧵
Magnus Isaksson retweeted
The chatter about Omicron subvariants BA.1, BA.1.1, and BA.2 made me curious how well @my_helix's assay covers mutations that distinguish them.
Thank you @Maglaar for making this data so easy to query and @nextstrain's nextclade cli for the annotations.
Magnus Isaksson retweeted
Is BA.2 going to take over in the US ?
So far, BA.2 is still <0.5% of sequences in @my_helix surveillance. Not growing in last 10 days.
23 Jan (collection date): 2 BA.2 out of 215 seq
24 Jan: 6 / 556
25 Jan: 3 / 344
26 Jan: 0 / 434
27 Jan: 0 / 225
public.tableau.com/app/profi…
Magnus Isaksson retweeted
Coming up next week...
Join us on Thurs., Feb. 10 at 12 p.m. EST for our next Genomic & Precision Medicine Forum featuring Liz Cirulli, PhD (@ETCirulli) from @my_helix
Register in Advance: duke.is/j647p
Magnus Isaksson retweeted
Some discussions about BA.2 recently (see 🧵). Do we see BA.2 in @my_helix surveillance?
Dashboard now shows B.1.1.529, BA.1 & BA.2
Out of 3,801 samples collected in 2022 & sequenced: only 3 BA.2.
1 in CA, 1 in FL, 1 in LA
public.tableau.com/app/profi…
Magnus Isaksson retweeted
Impressive work @alexbolze and team @my_helix. 6 day turn around from sample collection to sequence publication & sharing is impressive. @PPI_Insights
Latest @my_helix sequencing:
Omicron: 97% for samples collected on January 9 (n=170)
Delta: hanging at ~3%
Similar to results from @NathanGrubaugh & @pavitrarc in US.
source: public.tableau.com/app/profi…
Magnus Isaksson retweeted
Latest @my_helix sequencing:
Omicron: 97% for samples collected on January 9 (n=170)
Delta: hanging at ~3%
Similar to results from @NathanGrubaugh & @pavitrarc in US.
source: public.tableau.com/app/profi…
Magnus Isaksson retweeted
Again takes many teams to have 6 days between sample collection -> diagnostic test -> sequencing -> analysis to results on dashboard
Thanks @sustain_SCM ops team, @Maglaar @shishiluo bioinfo team
& external support + discussions to keep improving
@dmaccannell @RickABright
Magnus Isaksson retweeted
New! @ETCirulli & colleagues identify an HLA allele associated with side effects from the Pfizer #COVID19 vaccine https://nitter.cf/t.co/dD7qJzoRJk
#OA @GeneticsSociety
Magnus Isaksson retweeted
Help our nation continue the fight against #COVID by working in Helix’s San Diego lab. We offer both referral and sign-on bonuses and are actively #hiring.
Specimen Handler: lnkd.in/gbGkqn8G
Clinical Lab Technician: lnkd.in/gj6Cz8MQ
Magnus Isaksson retweeted
So excited to have our study out on @medrxivpreprint showing that people with HLA-A*03:01 are twice as likely to get fevers and chills after Pfizer-BioNTech vaccination compared to those without this HLA type @alexbolze @my_helix @HealthyNV @grzymski @genesareclever
HLA-A*03:01 is associated with increased risk of fever, chills, and more severe reaction to Pfizer-BioNTech COVID-19 vaccination medrxiv.org/cgi/content/shor… #medRxiv
Magnus Isaksson retweeted
New rare variant data published by Helix researchers in @GIMJournal shows the inclusion of 4 novel conditions, all actionable with >30% penetrance, may broaden the impact of population genetic screening, identifying 27% more at-risk participants: blog.helix.com/population-ge…
Magnus Isaksson retweeted
Update on Alpha, Gamma & Delta. Check our updated preprint: medrxiv.org/content/10.1101/…
- Alpha now < 3% in US
- Delta taking over. incl. outcompeting Gamma.
- Analysis of Cq levels suggests Delta infections lead to higher viral loads.
Details in 🧵
























